These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7605424)

  • 1. Assessment of the validity of the INR system for patients with liver impairment.
    Kovacs MJ; Wong A; MacKinnon K; Weir K; Keeney M; Boyle E; Cruickshank M
    Thromb Haemost; 1994 Jun; 71(6):727-30. PubMed ID: 7605424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discrepant sensitivity of thromboplastin reagents to clotting factor levels explored by the prothrombin time in patients on stable oral anticoagulant treatment: impact on the international normalized ratio system.
    Testa S; Morstabilini G; Fattorini A; Galli L; Denti N; D'Angelo A
    Haematologica; 2002 Dec; 87(12):1265-73. PubMed ID: 12495900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validity of the INR system for patients with liver impairment.
    Denson KW; Reed SV; Haddon ME
    Thromb Haemost; 1995 Jan; 73(1):162. PubMed ID: 7740488
    [No Abstract]   [Full Text] [Related]  

  • 4. Standardization of coagulation tests.
    Opartkiattikul N
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 3():79-85. PubMed ID: 10926265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of three prothrombin time and activated partial thromboplastin time reagent systems on the MLA 700 coagulation analyzer.
    Kritikos VG; Melhem MF
    Clin Lab Sci; 1993; 6(5):302-7. PubMed ID: 10146556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International standardization of laboratory control of oral anticoagulant therapy: a survey of thromboplastin reagents used for prothrombin time testing.
    van den Besselaar AM
    J Heart Valve Dis; 1993 Jan; 2(1):42-52. PubMed ID: 8269109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of melagatran on prothrombin time assays depends on the sensitivity of the thromboplastin and the final dilution of the plasma sample.
    Mattsson C; Menschiek-Lundin A; Wåhlander K; Lindahl TL
    Thromb Haemost; 2001 Aug; 86(2):611-5. PubMed ID: 11522011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between CoaguChek S- and Owren-type prothrombin time assay for monitoring anticoagulant therapy.
    Jonsson M; Hillarp A; Svensson P
    Thromb Res; 2004; 114(2):83-9. PubMed ID: 15306149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of frozen plasma calibrants for enhanced standardization of the international normalized ratio (INR): a multi-center study.
    Adcock DM; Johnston M
    Thromb Haemost; 2002 Jan; 87(1):74-9. PubMed ID: 11848460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Warfarin monitoring independent of the international normalized ratio (INR): a pilot study.
    Carroll WE; Jackson RD
    Res Commun Mol Pathol Pharmacol; 1997 Feb; 95(2):169-78. PubMed ID: 9090753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of EDTA samples for prothrombin time measurement in patients receiving oral anticoagulants.
    Horsti J
    Haematologica; 2001 Aug; 86(8):851-5. PubMed ID: 11522542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral anticoagulant therapy and international normalized ratios in swine.
    McGlasson DL; Brickey DA; Doe RH
    Lab Anim Sci; 1998 Aug; 48(4):371-3. PubMed ID: 10090045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prothrombin time in liver failure: time, ratio, activity percentage, or international normalized ratio?
    Robert A; Chazouillères O
    Hepatology; 1996 Dec; 24(6):1392-4. PubMed ID: 8938167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The application of thrombin generation tests to warfarin anticoagulation monitoring].
    Chen HY; Ding QL; Zhang LW; Xu GQ; Dai J; Wang XF; Xi XD; Wang HL
    Zhonghua Xue Ye Xue Za Zhi; 2008 Mar; 29(3):168-70. PubMed ID: 18788615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of validity of INR system for patients with liver disease associated with viral hepatitis.
    Wei Y; Li J; Zhang L; Zheng D; Shi B; Cong Y
    J Thromb Thrombolysis; 2010 Jul; 30(1):84-9. PubMed ID: 19915802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Point-of-care monitoring of oral anticoagulation therapy in children. Comparison of the CoaguChek XS system with venous INR and venous INR using an International Reference Thromboplastin preparation (rTF/95).
    Greenway A; Ignjatovic V; Summerhayes R; Newall F; Burgess J; DeRosa L; Monagle P
    Thromb Haemost; 2009 Jul; 102(1):159-65. PubMed ID: 19572081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implications of use of low international sensitivity index thromboplastins in prothrombin time testing.
    Ts'ao C; Swedlund J; Neofotistos D
    Arch Pathol Lab Med; 1994 Dec; 118(12):1183-7. PubMed ID: 7979911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poor correlation of supratherapeutic international normalised ratio and vitamin K-dependent procoagulant factor levels during warfarin therapy.
    Sarode R; Rawal A; Lee R; Shen YM; Frenkel EP
    Br J Haematol; 2006 Mar; 132(5):604-7. PubMed ID: 16445834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Laboratory control over warfarin therapy in patients with acute coronary syndrome].
    Baluda MV; Lopukhina MV; Fomina VM; Lopukhin VO
    Ter Arkh; 2005; 77(10):68-71. PubMed ID: 16320690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Suggestions and propositions to resolve some issues for standardization of prothrombin time and activated partial thromboplastin time].
    Kagawa K; Fukutake K
    Rinsho Byori; 1999 May; 47(5):431-7. PubMed ID: 10375964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.